Sotrovimab
Sotrovimab (VIR 7831) is a monoclonal antibody against the SARS-CoV-2 virus that causes COVID-19. It has antiviral activity, induces serum neutralization of BQ.1 and antibody-dependent cytotoxicity, and may be used to study viral infections.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
SARS-CoV
CAS Number
2423014-07-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![1'- (tert-Butoxycarbonyl) -[1,3'-biazetidine]-3-carboxylic acid](https://cdn.genprice.uk/genprice/genprice5.png)
![1'- (tert-Butoxycarbonyl) -[1,3'-biazetidine]-3-carboxylic acid](https://cdn.genprice.uk/genprice/genprice4.png)
OR1067947-02 100 mg
1'- (tert-Butoxycarbonyl) -[1,3'-biazetidine]-3-carboxylic acid
Ask
View Details OR1067947-03 250 mg
1'- (tert-Butoxycarbonyl) -[1,3'-biazetidine]-3-carboxylic acid
Ask
View Details